Medical Innovation Acceleration Act of 2025

Cost and committee reports

Official records Congress.gov attaches to H.R. 88.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. BIGGS of Arizona, as printed in the Congressional Record (Vol. 171, No. 1, January 3, 2025, Page H38):
  Article I, Section 8 The single subject of this legislation is: The single subject of this bill is to amend the Federal Food, Drug, and Cosmetic Act to exempt from regulation as devices non-invasive diagnostic devices.
  Source: Congress.gov, Congressional Record January 3, 2025 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  218 characters

  Congress.gov bill record

  H.R. 88, 119th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/119/hr/88

  Record last updated by Congress.gov

  January 14, 2026

  PORKER copy retrieved

  September 13, 2026

  Stored copy, SHA-256 of the file

  e8451703323f9a33de2e74ed014d9cb0d3e640baac520f5c71806cbed6f825e1

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of January 14, 2026). Not every bill gets one.

From the Congress.gov bill record for H.R. 88, last updated January 14, 2026. PORKER’s copy was retrieved September 13, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.